Novel exenatide analogs with peptidic albumin binding domains: potent anti-diabetic agents with extended duration of action.

The design, synthesis and pharmacology of novel long-acting exenatide analogs for the treatment of metabolic diseases are described. These molecules display enhanced pharmacokinetic profile and potent glucoregulatory and weight lowering actions compared to native exenatide. [Leu(14)]exenatide-ABD is an 88 residue peptide amide incorporating an Albumin Binding Domain (ABD) scaffold. [Leu(14)]exenatide-ABP is a 53 residue peptide incorporating a short Albumin Binding Peptide (ABP). [Leu(14)]exenatide-ABD and [Leu(14)]exenatide-ABP exhibited nanomolar functional GLP-1 receptor potency and were metabolically stable in vitro in human plasma and in a pancreatic digestive enzyme mixture. Both molecules displayed picomolar and nanomolar binding association with albumin across multiple species and circulating half lives of 16 and 11 hours, respectively, post a single IV dose in rats. Unlike exenatide, both molecules elicited robust glucose lowering when injected 1 day prior to an oral glucose tolerance test, indicative of their extended duration of action. [Leu(14)]exenatide-ABD was compared to exenatide in a Lep (ob/ob) mouse model of diabetes. Twice-weekly subcutaneously dosed [Leu(14)]exenatide-ABD displayed superior glucose lowering and weight loss in diabetic mice when compared to continuously infused exenatide at the same total weekly dose. A single oral administration of each molecule via an enteric coated capsule to cynomolgus monkeys showed superior pharmacokinetics for [Leu(14)]exenatide-ABD as compared to [Leu(14)]exenatide-ABP with detectable exposure longer than 14 days. These studies support the potential use of these novel long acting exenatide analogs with different routes of administration for the treatment of type 2 diabetes.

Improved glucose control and reduced body weight in rodents with dual mechanism of action peptide hybrids.

Combination therapy is being increasingly used as a treatment paradigm for metabolic diseases such as diabetes and obesity. In the peptide therapeutics realm, recent work has highlighted the therapeutic potential of chimeric peptides that act on two distinct receptors, thereby harnessing parallel complementary mechanisms to induce additive or synergistic benefit compared to monotherapy. Here, we extend this hypothesis by linking a known anti-diabetic peptide with an anti-obesity peptide into a novel peptide hybrid, which we termed a phybrid. We report on the synthesis and biological activity of two such phybrids (AC164204 and AC164209), comprised of a glucagon-like peptide-1 receptor (GLP1-R) agonist, and exenatide analog, AC3082, covalently linked to a second generation amylin analog, davalintide. Both molecules acted as full agonists at their cognate receptors in vitro, albeit with reduced potency at the calcitonin receptor indicating slightly perturbed amylin agonism. In obese diabetic Lep(ob)/Lep (ob) mice sustained infusion of AC164204 and AC164209 reduced glucose and glycated haemoglobin (HbA1c) equivalently but induced greater weight loss relative to exenatide administration alone. Weight loss was similar to that induced by combined administration of exenatide and davalintide. In diet-induced obese rats, both phybrids dose-dependently reduced food intake and body weight to a greater extent than exenatide or davalintide alone, and equal to co-infusion of exenatide and davalintide. Phybrid-mediated and exenatide + davalintide-mediated weight loss was associated with reduced adiposity and preservation of lean mass. These data are the first to provide in vivo proof-of-concept for multi-pathway targeting in metabolic disease via a peptide hybrid, demonstrating that this approach is as effective as co-administration of individual peptides.

Polyoxotungstate stabilized palladium, gold, and silver nanoclusters: a study of cluster stability, catalysis, and effects of the stabilizing anions.

Polyoxometalates (POMs) have demonstrated the unusual ability to both stabilize nanoclusters and facilitate catalytic activity by allowing substrate access to sufficient metallic surface area. This paper presents a wet chemical synthetic method to prepare Pd, Ag, and Au metal nanoclusters stabilized by tetrabutylammonium salts of Phosphotungstates with the well-known Keggin [α-PW(12)O(40)](3-) (PW(12)), Wells-Dawson [P(2)W(18)O(62)](6-) (P(2)W(18)), and their lacunary derivatives [α-PW(11)O(39)](7-) (PW(11)) and [P(2)W(15)O(56)](12-) (P(2)W(15)) structures. The preparation of this series of nanoclusters has facilitated a comparison of the effect these anions have in nanocluster stabilization and catalysis. The nanocluster systems were found to be re-dispersible in acetonitrile and acetone. The effect of aging on stability was followed over 3 months and it was found that many systems were very stable for more than 70 days without precipitation, depending on type of polytungstate stabilizer and the presence of competing ions. The PW(12), P(2)W(18), PW(11), and P(2)W(15) stabilized Pd nanoclusters have been investigated for catalytic activity in the hydrogenation of 1-hexene and were found to be very active with the P(2)W(18) stabilized Pd nanoclusters demonstrating a best of 139,000 Total Turnovers, thus ranking this "soluble heterogeneous catalyst" among one of the longest lived reported in the literature. The nanocluster systems were characterized using instrumental techniques such as UV-Visible Spectroscopy, FTIR Spectroscopy, Powder X-ray Diffraction, Energy Dispersive Spectroscopy, X-ray Photoelectron Spectroscopy, and Transmission Electron Microscopy.

Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent models.

Antagonism of opioid systems (e.g., with naltrexone) has been explored as an anti-obesity strategy, and is particularly effective when co-administered with dual inhibitors of dopamine and norepinephrine reuptake (e.g., bupropion). Previously, we demonstrated that amylin enhances the food intake lowering and weight loss effects of neurohormonal (e.g., leptin, cholecystokinin, melanocortins) and small molecule (e.g., phentermine, sibutramine) agents. Here, we sought to characterize the interaction of amylin with naltrexone/bupropion on energy balance. Wild-type and amylin knockout mice were similarly responsive to the food intake lowering effects of either naltrexone (1mg/kg, subcutaneous) or bupropion (50mg/kg, subcutaneous) suggesting that they act independently of amylinergic systems and could interact additively when given in combination with amylin. To test this, diet-induced obese rats were treated (for 11 days) with vehicle, rat amylin (50 µg/kg/d, infused subcutaneously), naltrexone/bupropion (1 and 20mg/kg, respectively by twice daily subcutaneous injection) or their combination. We found that amylin+naltrexone/bupropion combination therapy exerted additive effects to reduce cumulative food intake, body weight and fat mass. In a separate study, the effects of amylin and naltrexone/bupropion administered at the same doses (for 14 days) were compared to a pair-fed group. Although the combination and pair-fed groups lost a similar amount of body weight, rats treated with the combination lost 68% more fat and better maintained their lean mass. These findings support the strategy of combined amylin agonism with opioid and catecholaminergic signaling systems for the treatment of obesity.

Supramolecular carbon nanotube-fullerene donor-acceptor hybrids for photoinduced electron transfer.

Photoinduced electron transfer in a self-assembled single-wall carbon nanotube (SWNT)-fullerene(C60) hybrid with SWNT acting as an electron donor and fullerene as an electron acceptor has been successfully demonstrated. Toward this, first, SWNTs were noncovalently functionalized using alkyl ammonium functionalized pyrene (Pyr-NH3+) to form SWNT/Pyr-NH3+ hybrids. The alkyl ammonium entity of SWNT/Pyr-NH3+ hybrids was further utilized to complex with benzo-18-crown-6 functionalized fullerene, crown-C60, via ammonium-crown ether interactions to yield SWNT/Pyr-NH3+/crown-C60 nanohybrids. The nanohybrids were isolated and characterized by TEM, UV-visible-near IR, and electrochemical methods. Free-energy calculations suggested possibility of electron transfer from the carbon nanotube to the singlet excited fullerene in the SWNT/Pyr-NH3+/crown-C60 nanohybrids. Accordingly, steady-state and time-resolved fluorescence studies revealed efficient quenching of the singlet excited-state of C60 in the nanohybrids. Further studies involving nanosecond transient absorption studies confirmed electron transfer to be the quenching mechanism, in which the electron-transfer product, fullerene anion radical, was possible to spectrally characterize. The rates of charge separation, kCS, and charge recombination, kCR, were found to be 3.46 x 10(9) and 1.04 x 10(7) s-1, respectively. The calculated lifetime of the radical ion-pair was found to be over 100 ns, suggesting charge stabilization in the novel supramolecular nanohybrids. The present nanohybrids were further utilized to reduce hexyl-viologen dication (HV2+) and a sacrificial electron donor, 1-benzyl-1,4-dihydronicotinamide, in an electron-pooling experiment, offering additional proof for the occurrence of photoinduced charge-separation and potential utilization of these materials in light-energy harvesting applications.

Self-assembled single-walled carbon nanotube:zinc-porphyrin hybrids through ammonium ion-crown ether interaction: construction and electron transfer.

An ammonium ion-crown ether interaction has been successfully used to construct porphyrin-single-walled carbon nanotube (SWNT) donor-acceptor hybrids. The [18]crown-6 to alkyl ammonium ion binding strategy resulted in porphyrin-SWNT nanohybrids that are stable and soluble in DMF. The porphyrin-SWNT hybrids were characterized by spectroscopic, TEM, and electrochemical techniques. Both steady-state and time-resolved emission studies revealed efficient quenching of the singlet excited state of the porphyrins and free-energy calculations suggested that electron-transfer quenching occurred. Nanosecond transient absorption spectral results supported the charge-separation quenching process. Charge-stabilization was also observed for the nanohybrids in which the lifetime of the radical ion pairs was around 100 ns. The present nanohybrids were also used to reduce the hexyl viologen dication (HV2+) and to oxidize 1-benzyl-1,4-dihydronicotinamide in solution in an electron-pooling experiment. Accumulation of the radical cation (HV.+) was observed in high yields, which provided additional proof for the occurrence of photoinduced charge separation. The present study demonstrates that a hydrogen-bonding motif is a successful self-assembly method to build SWNTs bearing donor-acceptor nanohybrids, which are useful for light-energy harvesting and photovoltaic applications.

Rhenium(VII) oxide catalyzed heteroacylative ring-opening dimerization of tetrahydrofuran.

Re(2)O(7), which is known primarily as a strong oxidant, was found to be a highly selective Lewis acid catalyst that affects the heteroacylative dimerization of THF at room temperature. This multicomponent reaction, which involves THF, trifluoroacetic anhydride (TFAA), and a carboxylic acid, produces a nonsymmetrical diester, RCO(2)(CH(2))(4)O(CH(2))(4)OCOCF(3), in high yields. The reaction is quite general with respect to the carboxylic acid but is highly selective for unsubstituted THF in preference to other cyclic ethers. It is also highly selective for TFAA in preference to other anhydrides. Isotope labeling experiments indicate that two of the five oxygen atoms in the product originate from THF; one comes from rhenium oxide, and the two carbonyl oxygens originate from the carboxylic acid and from TFAA. The catalytic cycle, which is proposed on the basis of these experiments, involves a multistep sequence of nucleophilic attacks, starting with an attack of a rhenium oxo ligand on a coordinated THF, then attack of the resultant alkoxide ligand on a second coordinated THF, nucleophilic addition of the resultant alkoxide ligand to the coordinated carboxylic acid (an intramolecular metal-oxygen bond metathesis), and, finally, electrophilic cleavage of the other coordinated alkoxide by TFAA to produce the nonsymmetrical diester. This synthetically useful reaction highlights the unique, frequently avoided Lewis acidity of transition-metal oxides.

A colloid "digesting" route to novel, thermally stable high surface area ZrO2 and Pd/ZrO2 catalytic materials.

Zirconia having high thermal stability and high surface area (up to 160 m(2)/g at 700 degrees C) has been prepared by a colloidal "digesting" process. This material having demonstrated high surface areas at elevated temperatures was then applied as a catalyst support. A Pd colloid with diameter of approximately 12 nm has been successfully deposited on the high surface area zirconia material. All systems have been well characterized by TEM, X-ray diffraction, N2 adsorption isotherms, FTIR, elemental analysis and dynamic light scattering techniques. The colloidal Pd particles have been found homogeneously well dispersed in the hydrous zirconia matrix without aggregation. The Pd/ZrO2 catalysts have been screened for cyclohexene and 1-hexene hydrogenation activity and it was found that the catalyst is extremely active.

In situ approaches to establish colloidal growth kinetics.

A technique based on the back scattering phenomenon of dynamic light scattering has been employed to monitor the kinetics of gold and platinum metal nanoparticle growth and silver nanoparticle oxidation as well as in the determination of particle sizes ranging from 1 to 200 nm in diameter. The systems were chosen to examine the applicability of dynamic light scattering to nanoresearch over a broad range of sizes as well as both metallic and nonmetallic systems. The advantages of this instrumentation over traditional instruments such as X-ray diffraction (XRD), transmission electron microscopy (TEM), and scanning electron microscopy (SEM) have been highlighted.

Total synthesis of 34-hydroxyasimicin and its photoactive derivative for affinity labeling of the mitochondrial complex I.

The asymmetric total synthesis of the 34-hydroxyasimicin and its 3-(4-benzoylphenyl)propionate ester was achieved by means of a convergent synthetic strategy. This ester, which contains eight asymmetric centers, represents the first photoaffinity-labeling agent that is derived from an Annonaceous acetogenin. The key transformations in the synthesis include the Sharpless asymmetric dihydroxylation reaction, the Wittig olefination reaction, an oxidative cyclization reaction with rhenium(vii) oxide, the Williamson etherification reaction, and a palladium-catalyzed cross-coupling reaction. Use of the target molecule for photoaffinity-labeling studies of bovine mitochondrial NADH-ubiquinone oxidoreductase (Complex I) may shed light on the structure/function of this intricate enzyme and on the origin of the high antitumor activity exhibited by the Annonaceous acetogenins.

Efficient syntheses of benzothiazepines as antagonists for the mitochondrial sodium-calcium exchanger: potential therapeutics for type II diabetes.

Type II diabetes mellitus is a chronic metabolic disorder that can lead to serious cardiovascular, renal, neurologic, and retinal complications. While several drugs are currently prescribed to treat type II diabetes, their efficacy is limited by mechanism-related side effects (weight gain, hypoglycemia, gastrointestinal distress), inadequate efficacy for use as monotherapy, and the development of tolerance to the agents. Consequently, combination therapies are frequently employed to effectively regulate blood glucose levels. We have focused on the mitochondrial sodium-calcium exchanger (mNCE) as a novel target for diabetes drug discovery. We have proposed that inhibition of the mNCE can be used to regulate calcium flux across the mitochondrial membrane, thereby enhancing mitochondrial oxidative metabolism, which in turn enhances glucose-stimulated insulin secretion (GSIS) in the pancreatic beta-cell. In this paper, we report the facile synthesis of benzothiazepines and derivatives by S-alkylation using 2-aminobenzhydrols. The syntheses of other bicyclic analogues based on benzothiazepine, benzothiazecine, benzodiazecine, and benzodiazepine templates are also described. These compounds have been evaluated for their inhibition of mNCE activity, and the results from the structure-activity relationship (SAR) studies are discussed.

Mutants of 4-oxalocrotonate tautomerase catalyze the decarboxylation of oxaloacetate through an imine mechanism.

A designed single amino acid substitution can alter the catalytic activity and mechanism of 4-oxalocrotonate tautomerase (4-OT). While the wild-type enzyme catalyzes only the tautomerization of oxalocrotonate, the Pro1Ala mutant (P1A) catalyzes two reactions--the original tautomerization reaction and the decarboxylation of oxaloacetate. Although the N-terminal amine group of P1A is involved in both reactions, our results support a nucleophilic mechanism for the decarboxylase activity, in contrast to the general acid/base mechanism that has been previously established for the tautomerase activity. These findings demonstrate that a single catalytic group in a 4-OT mutant can catalyze two reactions by two different mechanisms.

Remarkable remote chiral recognition in a reaction mediated by a catalytic antibody.

The crystal structures of catalytic antibody D2.3 Fab with the two enantiomers, 7D and 7L, which represent transition state analogues for the hydrolysis of the corresponding esters, 6D and 6L, were determined to better understand remarkable reactivity differences: the L-ester displayed significantly tighter binding (K(M)) and increased catalytic activity (k(cat)) with D2.3, even though the chiral center is 7 bonds distant from the reaction center. Surprisingly, the electron densities of the liganded phosphonates, 7D and 7L, within the D2.3 binding/reaction site were essentially identical, highlighting the subtle influences of protein interactions on chemical behavior.

Silver-palladium nanodispersions in silicate matrices: highly uniform, stable, bimetallic structures.

Ag-Pd nanobimetallic colloidal particles are prepared in a single step by a chemical reduction method. Organically modified aminosilicate is used as a supporting matrix as well as a stabilizing agent, to obtain very uniform, well-distributed bimetallic particles. These nanoparticles are found to be stable for several months in both the solid and the liquid phases. The structure of the bimetallic particles has been followed by X-ray photoelectron spectroscopy and ultraviolet-visible spectroscopy. The distribution and the particle size are determined by transmission electron microscope and X-ray diffraction studies. Polymerization and condensation of the support silicate material have been confirmed by Fourier transform infrared spectroscopy.